Editorial
Copyright ©2012 Baishideng Publishing Group Co.
World J Cardiol. May 26, 2012; 4(5): 135-147
Published online May 26, 2012. doi: 10.4330/wjc.v4.i5.135
Table 1 Classification of blood pressure for adults according to JNC-7
ClassificationSBP (mmHg)DBP (mmHg)
Normal ≤ 120And ≤ 80
Prehypertension120-139Or 80-89
Stage 1 hypertension140-159Or 90-99
Stage 2 hypertension≥ 160Or ≥ 100
Table 2 Classification of blood pressure for adults according to ESH/ESC 2007
ClassificationSBP (mmHg)DBP (mmHg)
Οptimal ≤ 120And ≤ 80
Normal120-12980-84
High normal130-13985-89
Hypertension
Grade 1 (mild)140-15990-99
Grade 2 (moderate)160-179100-109
Grade 3 (severe)≥ 180≥ 100
Isolated systolic hypertension≥ 140 ≤ 90
Table 3 Causes of secondary hypertension
Hyperaldosteronism
Cushing syndrome
Coarctation of the aorta
Renovascular stenosis
Endocrine disorders (thyroid, parathyroid abnormalities)
Obstructive sleep apnea
Drugs (nonsteroidal antiinflammatory drugs, alcohol, estrogen)
Chronic kidney disease
Pheochromocytoma
Table 4 Causes of resistant hypertension
False positive or pseudoresistance
Incorrect technique in measuring blood pressure
Pseudohypertension
Lack of adherence to life style modifications
Lack of patient adherence to antihypertensive therapy
Suboptimal therapy
True resistant hypertension
Sleep apnea
Hypertension related to secondary etiology
Table 5 Therapeutic strategies
Non-pharmacological strategy
Weight reduction
Dietary sodium reduction
Physical activity
Moderate alcohol consumption
Dash diet
Pharmacological strategy
Main Pharmacological agents
Thiazide diuretic: inhibiting reabsorption of sodium (Na+) and chloride (Cl-) ions from the distal convoluted tubules in the kidneys →→↓ BP, ↓ stroke, ↓ CV mortality
ACEIs: block the conversion of angiotensin I to angiotensin II →→↓ SVR, ↓ BP, ↓ mortality in patients with MI and left ventricular dysfunction, ↓ progression of diabetic renal disease
ARBs: direct blockage of angiotensin II receptors →→ vasodilation (↓SVR), ↓ secretion of vasopressin, ↓ aldosterone, ↓ BP, ↓ stroke. Generally, in patients who cannot tolerate ACEs
Calcium antagonists: disrupts the movement of calcium through calcium channels in cardiac muscle and peripheral arteries →→ vasodilation (↓ SVR), ↓ BP, ↓ CV complications in elderly patients with ISH
β blockers: ↓ heart rate, ↓ cardiac contractility, ↓ cardiac output, inhibit renin release, ↑ nitric oxide, ↓ vasomotor tone →→↓ BP
Other agents: direct renin inhibitors, aldosterone receptor antagonists, centrally acting agents, direct vasodilators, α-adrenergic blocking agents
Combination therapy
ACEIs or ARBs/Diuretic
ACEIs or ARBs/Calcium antagonist (especially in patients with high CV risk)